1 day ago
Moderna (MRNA) Stock Climbs as Company Launches Ebola Vaccine Trial in Canada
Moderna (MRNA) stock rises 4.37% as the company launches Phase 1 human trials for its Bundibugyo Ebola vaccine in Canada with $50M CEPI funding support.
The post Moderna (MRNA) Stock Climbs as Company Launches Ebola Vaccine Trial in Canada appeared first on Blockonomi.
Source: Blockonomi →Related News
- 3 hours ago
Beyond Meat (BYND) Stock: Falls as Q2 Revenue Declines and Adjusted EBITDA Loss...
- 3 hours ago
MercadoLibre (MELI) Stock: Sinks After Hours Despite 50% Revenue Growth and Fint...
- 4 hours ago
Figma Inc. (FIG) Stock: Plunges 15% Despite 48% Q2 Revenue Growth and AI Monetiz...
- 5 hours ago
SoundHound AI (SOUN) Stock: Rebounds 13% as Q2 Revenue Jumps 45%
- 5 hours ago
Sandisk Corporation (SNDK) Stock: Slides Despite 372% Q4 Revenue Surge and $14 B...